GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (NAS:GHRS) » Definitions » Common Stock

GH Research (GH Research) Common Stock : $1.30 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is GH Research Common Stock?

GH Research's quarterly common stock stayed the same from Jun. 2023 ($1.30 Mil) to Sep. 2023 ($1.30 Mil) and stayed the same from Sep. 2023 ($1.30 Mil) to Dec. 2023 ($1.30 Mil).

GH Research's annual common stock stayed the same from Dec. 2021 ($1.30 Mil) to Dec. 2022 ($1.30 Mil) and stayed the same from Dec. 2022 ($1.30 Mil) to Dec. 2023 ($1.30 Mil).

GH Research Common Stock Historical Data

The historical data trend for GH Research's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Common Stock Chart

GH Research Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
0.80 0.87 1.30 1.30 1.30

GH Research Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.30 1.30 1.30 1.30 1.30

GH Research Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

GH Research (GH Research) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (NAS:GHRS) » Definitions » Common Stock
Comparable Companies
IMNM CDMO BMEA MRNS ORTX ALXO ORIC RNA ITOS URGN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
1KA:Germany
Address
28 Baggot Street Lower, Dublin, IRL, D02 NX43
Website
https://www.ghres.com
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.